期刊文献+

心肾综合征病理生理机制的研究进展 被引量:8

Research progress in pathophysiological mechanism in cardiorenal syndrome
下载PDF
导出
摘要 传统的心肾综合征(CRS)指慢性心力衰竭引起的进行性肾功能损害、利尿剂抵抗和心脏容量负荷过重,最终导致心力衰竭恶化的一系列病理变化。随着研究的不断深入,CRS的定义范围得到大大扩展。CRS的发病机制复杂,至今尚未阐清,本文就近年CRS病理生理机制的研究进展进行了综述。 The traditional definition of cardiorenal syndrome (CRS) is a series of pathological changes when chronic failure causes progressive renal injury, diuretic resistance, heart volume overload and, finally, worsening of heart failure. With additional research, the definition range of CRS has been greatly extended. The pathogenesis of CRS is complex and still remains unclear. This review presents recent research progress in pathophysiological mechanisms for CRS.
出处 《心脏杂志》 CAS 2012年第4期544-545,548,共3页 Chinese Heart Journal
基金 国家自然科学基金项目资助(81072924)
关键词 心肾综合征 病理生理学 机制 cardiorenal syndromes pathophysiology mechanisms
  • 相关文献

参考文献8

  • 1Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interac- tions: Insights from the ESCAPE trial [ J ]. J Am Coll Cardiol, 2008, 51 ( 13 ) : 1268 - 1274.
  • 2Liu PP. Cardiorenal syndrome in heart failure: a cardiologist's per- spective[ J]. Can J Cardiol, 2008, 24(suppl B) :25B - 29B.
  • 3Brown JR, Uber PA, Mehra MR. The progressive cardiorenal syn- drome in heart failure: mechanisms and therapeutic insights [ J ]. Curr Treat Options Cardiovasc Med, 2008, 10(4) :342 -348.
  • 4Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a muhicentre safety and proof-of-principle cohort study [ J ]. Lancet, 2009, 373 (9671) :1275 - 1281.
  • 5Mitchell MD, Laird RE, Brown RD, et al. IL-1 beta stimulates rat cardiac fibroblast migration via MAP kinase pathways [ J ]. Am J Physiol Heart C irc Physiol, 2007, 29 (2) : H1139 - H1147.
  • 6Silva RP, Barbosa PH, Kimura OS, et al. Prevalance of anemia and its association with cardio-renal syndrome [ J ]. lnt J Cardiol, 2007, 120(2) :232 - 236.
  • 7O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure-results of the candesartan in heart failure: assessment of reduction in mortality and morbidity ( CHARM ) program [ J ]. Circulation, 2006, 113 (7) :986 - 994.
  • 8Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome[ J]. J Am CoU Cardiol, 2008, 52(19) :1527 - 1539.

同被引文献95

引证文献8

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部